Medical Communications

Showing 15 posts of 6408 posts found.

dominic_caruso

J&J’s longest-standing CFO finally steps down

March 21, 2018 Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical

Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …
john_mchutchison

New Chief Science and Medical Officers for Gilead

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018 Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

Rising levels of opioid prescriptions puts NHS under pressure

March 16, 2018 Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical

It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …

NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy

March 16, 2018 Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …

Allergan navigating choppy waters, as shares rise and fall

March 16, 2018 Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …
ears-2545756_960_720

Hearing drug failure puts biotech on brink

March 16, 2018 Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
william_pao

Roche appoints new research and early development head

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Andrew Witty takes on a new CEO position

March 15, 2018 Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …
veeva_event

Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe

March 15, 2018 Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …
philip_hammond

Hammond suggests NHS may receive cash boost

March 14, 2018 Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …
The Gateway to Local Adoption Series

Latest content